The Graduate Program in Cellular and Molecular Medicine (CMM) was created in 1993 and offers highly qualified Ph.D. candidates the opportunity to learn the theory and practice of modern cellular and molecular biology while conducting laboratory research on problems with direct clinical relevance. CMM is an independent Graduate Program at the Johns Hopkins School of Medicine with separate admissions, a special curriculum, and is certified to award the degree of Doctor of Philosophy (PhD). Now in its 16th year, CMM matriculates -18-25 incoming students selected from ~200 applicants every year. A total of 98 Students (as of May 2008) have graduated from the Program. CMM faculty members are from clinical departments and basic science departments. They were selected because of their successful independent laboratory programs, NIH funding, and their suitability to serve as mentors for young scientists. Importantly, CMM faculty pursues research at cellular and molecular levels on human diseases including: cancer;cardiopulmonary and vascular disorders;neurobiology and neurological disorders;immunological and infectious diseases;metabolic, developmental, and genetic defects. The goal of CMM is to train young scientists for careers studying human diseases at cellular and molecular levels. We expect that most CMM graduates will take academic positions in medical schools pursuing research in clinical departments, while some may choose to pursue research in industry.
Rapid progress in cellular and molecular biology has strongly impacted on clinical medicine, offering insights about the fundamental causes of many diseases. Now new discoveries in the laboratory can be applied rapidly to the diagnosis, treatment and prevention of disease. The trainees in this program are working precisely at this interface between science and medicine to contribute to the long term well being of society.
| Ong, Chin Siang; Zhou, Xun; Han, Jingnan et al. (2018) In vivo therapeutic applications of cell spheroids. Biotechnol Adv 36:494-505 |
| Forde, Patrick M; Chaft, Jamie E; Pardoll, Drew M (2018) Neoadjuvant PD-1 Blockade in Resectable Lung Cancer. N Engl J Med 379:e14 |
| Muth, Dillon C; Powell, Bonita H; Zhao, Zezhou et al. (2018) miRNAs in platelet-poor blood plasma and purified RNA are highly stable: a confirmatory study. BMC Res Notes 11:273 |
| Veenhuis, Rebecca T; Kwaa, Abena K; Garliss, Caroline C et al. (2018) Long-term remission despite clonal expansion of replication-competent HIV-1 isolates. JCI Insight 3: |
| Ong, Chin Siang; Yesantharao, Pooja; Huang, Chen Yu et al. (2018) 3D bioprinting using stem cells. Pediatr Res 83:223-231 |
| Piard, Juliette; Essien Umanah, George K; Harms, Frederike L et al. (2018) Reply: ATAD1 encephalopathy and stiff baby syndrome: a recognizable clinical presentation. Brain 141:e50 |
| Zhang, Ke; Daigle, J Gavin; Cunningham, Kathleen M et al. (2018) Stress Granule Assembly Disrupts Nucleocytoplasmic Transport. Cell 173:958-971.e17 |
| Fukudome, Daisuke; Hayes, Lindsay N; Faust, Travis E et al. (2018) Translocator protein (TSPO) and stress cascades in mouse models of psychosis with inflammatory disturbances. Schizophr Res : |
| Ihms, Elizabeth A; Urbanowski, Michael E; Bishai, William R (2018) Diverse Cavity Types and Evidence that Mechanical Action on the Necrotic Granuloma Drives Tuberculous Cavitation. Am J Pathol 188:1666-1675 |
| Li, Zheqi; Levine, Kevin M; Bahreini, Amir et al. (2018) Upregulation of IRS1 Enhances IGF1 Response in Y537S and D538G ESR1 Mutant Breast Cancer Cells. Endocrinology 159:285-296 |
Showing the most recent 10 out of 274 publications
